Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Kymriah Global Growth at Constant Currencies by Year
Kymriah Global Growth at Constant Currencies (% cc) (%)
Novartis Kymriah Global Growth at Constant Currencies: -15.0% in FY2025, down 3.0 pts from a year earlier.
Latest, FY2025
-15.0%
Period ended Dec 31, 2025
Change on a year earlier
-3.0 pts
-12.0% in FY2024
History
5 years
Since FY2020
Sources
5
Documents cited below
Where the FY2025 figure comes from
“|| Kymriah 4 | 381 | 443 | -14 | -15”
Source: Novartis Form 6-K (0001114448-26-000007) ↗
Reported in Form 6-K & Form 20-F.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Kymriah Global Growth at Constant Currencies (% cc) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | -15.0% | -3.0 pts | Novartis Form 6-K (0001114448-26-000007) ↗ |
| FY2024 | Dec 31, 2024 | -12.0% | -7.0 pts | Novartis Form 6-K (0001370368-25-000007) ↗ |
| FY2023 | Dec 31, 2023 | -5.0% | -3.0 pts | Novartis Form 6-K (0001370368-24-000007) ↗ |
| FY2022 | Dec 31, 2022 | -2.0% | – | Novartis Form 6-K (0001370368-23-000008) ↗ |
| FY2020 | Dec 31, 2020 | 68.0% | – | Novartis Form 6-K (0001370368-21-000008) ↗ |
Cite this data
StockData. (2026). Novartis Kymriah Global Growth at Constant Currencies (%), annual FY2020–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/brand-kymriah-yoy-cc-pct
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.